Literature DB >> 2761669

Loss of glutaminase-positive cortical neurons in Alzheimer's disease.

H Akiyama1, P L McGeer, S Itagaki, E G McGeer, T Kaneko.   

Abstract

Phosphate activated glutaminase (PAG) was evaluated in the neocortex of Alzheimer and control cases. Consistent with previously reported results in rat cerebral cortex, pyramidal cells were stained immunohistochemically by a PAG specific polyclonal rabbit antibody, especially in layers II, III and V. An Alzheimer's case showed drastic depletion of PAG-positive pyramidal neurons, especially in layers II and III. Cortical PAG levels by biochemical assay were reduced to 18% of control in a small series of Alzheimer's cases (n = 3), while choline acetyltransferase (ChAT) was reduced to 28% of control in the same tissue samples. PAG staining was also observed in large neurons of the rat neostriatum. Double immunostaining for PAG and ChAT established that these large neurons also contained both enzymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2761669     DOI: 10.1007/BF01000038

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  17 in total

1.  A glutamatergic corticostriatal path?

Authors:  P L McGeer; E G McGeer; U Scherer; K Singh
Journal:  Brain Res       Date:  1977-06-10       Impact factor: 3.252

2.  Localization of glutaminase in the rat neostriatum.

Authors:  E G McGeer; P L McGeer
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

3.  Production, characterization, and immunohistochemical application of monoclonal antibodies to glutaminase purified from rat brain.

Authors:  T Kaneko; Y Urade; Y Watanabe; N Mizuno
Journal:  J Neurosci       Date:  1987-01       Impact factor: 6.167

4.  Immunoaffinity purification of human choline acetyltransferase: comparison of the brain and placental enzymes.

Authors:  G Bruce; B H Wainer; L B Hersh
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

5.  Regulatory effects of fatty acyl-coenzyme A derivatives on phosphate-activated pig brain and kidney glutaminase in vitro.

Authors:  E Kvamme; I A Torgner
Journal:  Biochem J       Date:  1975-07       Impact factor: 3.857

6.  Localization of glutaminase-like and aspartate aminotransferase-like immunoreactivity in neurons of cerebral neocortex.

Authors:  J P Donoghue; R J Wenthold; R A Altschuler
Journal:  J Neurosci       Date:  1985-10       Impact factor: 6.167

7.  First visualization of glutamate and GABA in neurones by immunocytochemistry.

Authors:  J Storm-Mathisen; A K Leknes; A T Bore; J L Vaaland; P Edminson; F M Haug; O P Ottersen
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

8.  Immunohistochemical study of glutaminase-containing neurons in the cerebral cortex and thalamus of the rat.

Authors:  T Kaneko; N Mizuno
Journal:  J Comp Neurol       Date:  1988-01-22       Impact factor: 3.215

9.  gamma-Glutamyltransferase: normal cortical levels in Alzheimer disease.

Authors:  E G McGeer; E A Singh; P L McGeer
Journal:  Alzheimer Dis Assoc Disord       Date:  1987       Impact factor: 2.703

10.  Glutamate-positive neurons in the somatic sensory cortex of rats and monkeys.

Authors:  F Conti; A Rustioni; P Petrusz; A C Towle
Journal:  J Neurosci       Date:  1987-06       Impact factor: 6.167

View more
  10 in total

1.  Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients.

Authors:  Gulnur Sh Burbaeva; Irina S Boksha; Elena B Tereshkina; Olga K Savushkina; Lubov' I Starodubtseva; Marina S Turishcheva
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

2.  Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase.

Authors:  G Sh Burbaeva; I S Boksha; E B Tereshkina; O K Savushkina; T A Prokhorova; E A Vorobyeva
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

3.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

4.  In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes.

Authors:  Jeddidiah W D Griffin; Ying Liu; Patrick C Bradshaw; Kesheng Wang
Journal:  J Mol Neurosci       Date:  2018-02-13       Impact factor: 3.444

5.  Novel form of phosphate activated glutaminase in cultured astrocytes and human neuroblastoma cells, PAG in brain pathology and localization in the mitochondria.

Authors:  E Kvamme; L S H Nissen-Meyer; B A Roberg; I Aa Torgner
Journal:  Neurochem Res       Date:  2008-02-15       Impact factor: 3.996

6.  Alterations in Cerebral Cortical Glucose and Glutamine Metabolism Precedes Amyloid Plaques in the APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease.

Authors:  Jens V Andersen; Sofie K Christensen; Blanca I Aldana; Jakob D Nissen; Heikki Tanila; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2016-09-29       Impact factor: 3.996

7.  Amyloid β 1-42 induces hypometabolism in human stem cell-derived neuron and astrocyte networks.

Authors:  Marta A Tarczyluk; David A Nagel; H Rhein Parri; Erin H Y Tse; James E Brown; Michael D Coleman; Eric J Hill
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

Review 8.  New Functions of APC/C Ubiquitin Ligase in the Nervous System and Its Role in Alzheimer's Disease.

Authors:  Tanja Fuchsberger; Ana Lloret; Jose Viña
Journal:  Int J Mol Sci       Date:  2017-05-14       Impact factor: 5.923

Review 9.  Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?

Authors:  Jeddidiah W D Griffin; Patrick C Bradshaw
Journal:  Oxid Med Cell Longev       Date:  2017-02-05       Impact factor: 6.543

10.  Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 Mice.

Authors:  Kristen R Hollinger; Xiaolei Zhu; Elizabeth S Khoury; Ajit G Thomas; Kevin Liaw; Carolyn Tallon; Ying Wu; Eva Prchalova; Atsushi Kamiya; Camilo Rojas; Sujatha Kannan; Barbara S Slusher
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.